Alain Dassas - Alterola Biotech Insider

ALTA -- USA Stock  

USD 1.25  0.00  0.00%

  Executive
Mr. Alain Dassas is Independent Member of the Supervisory Board Representing APG at Altarea SCA. He is also a Member of the Companys Investment Committee, Audit Committee and Remuneration Committee. He is a graduate of the ESCP Europe business school and holds a Masters in Econometrics and a MS in Management from Stanford University
Age: 66        
909-584-5853  http://www.alterolabiotech.com
Dassas began his career with Chase Manhattan Bank in 1973. In 1983, he joined the Renault Group, where he successively served as Head of the representative office in New York, Head of banking relationships and financial markets, Finance Director of Renault Credit International, Head of Financial Operations and Head of Financial Services. In 2003, Mr. Dassas was appointed a member of the Renault Group Executive Committee, then Chairman of Renault F1 Team. In 2007, Mr. Dassas was named a member of the Executive Committee of Nissan Motor Company in Tokyo. Since 2010, Mr. Dassas has acted as a consultant for the Renault Group and as Chief Financial Officer of Segula Technologies. He is also a Director of Strategic Initiatives .

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. As of March 26, 2018, Alterola Biotech, Inc. operates as a subsidiary of London Pharma Holdings Limited. Alterola Biotech operates under Conglomerates classification in USA and traded on OTC Market. It employs 1 people.Alterola Biotech (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Alterola Biotech Leadership Team

Patrick Mazieres, Finance Director of Cogedim
Michael Freitag, President CEO, Treasurer, Secretary, Director
Christian Gournay, Deputy CEO in charge of Residential Property, Regions and Institutional Relations, Member of the Executive Committee
CharveriatLouis Blandine, Director of Marketing
Gilles Boissonnet, Deputy CEO in charge of retail property, Chairman of the Management Board of Altarea France, Member of the Executive Committee
Kyler Hardy, Chairman of the Board
Olivier Dubreuil, Permanent Representative of JN Holding on the Supervisory Board
Alain Dassas, Independent Member of the Supervisory Board Representing APG (ABP Fund)
Gautier Taravella, Member of the Supervisory Board
Frederic Laloum, Deputy CEO in charge of marketing and Member of the Management Board of Altarea France
Philippe Albert, Deputy CEO of Altarea France
Gilbert Plummerel, Cogedim Market Director
Jocelyn Verdelon, Commercial Property Investment Director at Cogedim
Francoise Debrus, Independent Member of the Supervisory Board
Philippe Ulivieri, Regional Property CEO at Cogedim
Rene Lauritsen, President CEO, Principal Executive Officer, CFO, Principal Financial Officer, Principal Accounting Officer, Director
Olivier Esteve, Permanent Representative of Fonciere des Regions as an Independent Member of the Supervisory Board
Ian Talbot, Director
Christian Musset, Chairman of Cogedim Vente
Laurian Douin, Director of Investment Operations of Altarea Cogedim Entreprise
Michael Bennett, Director
Ludovic Castillo, Managing Director of Altarea Italia, Member of the Executive Committee
Dominique Rongier, Independent Member of the Supervisory Board
Laurent Campredon, Legal Property Director of Altarea France
Michael OBrien, CFO
JeanFrederic Heinry, CEO of Altarea Cogedim Entreprise ? Promotion
Philippe Mauro, Group General Secretary
Nathalie Bardin, Group Communications Director
Ioannis Tsitos, Director
Peter Maddocks, CEO, Director
Philippe Bouvier, Cogedim Investment Director
Christopher Harris, Director
Alain Taravella, President Co-Manager, Member of the Executive Committee
Eric Dumas, Finance Director, Member of the Executive Committee
Alain Jodar, Deputy CEO in charge of portfolio and Member of the Management Board of Altarea France
Alan Carter, Interim President CEO
Manuel Colleaux, Deputy Regional CEO of Cogedim
Stephane Theuriau, Deputy CEO in charge of Office Property and Private Equity, Chairman of Cogedim Entreprise, Member of the Executive Committee
Christophe Bacque, Chairman of COGEDIM Residence
Jacques Nicolet, Chairman of the Supervisory Board, Member of the Executive Committee
Emeric Servin, Permanent Representative of Predica - Credit Agricole Assurances on the Supervisory Board
Fabrice Allouche, CEO of Cogedim Entreprise
Matthieu Taravella, Member of the Supervisory Board
Bruno Poulain, Director for Sustainable Development, Communications and Human Resources

Stock Performance Indicators

Did you try this?

Run Watchlist Optimization Now
   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Watchlist Optimization

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Alterola Biotech and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.